Search research articles
Contact Us
Filters
Showing results (41-50 of 331) with videos related to
Page
of 34
Sort By:
Cancer
|
June 22, 2010
The excessive cost of early stage bladder cancer care: are providers really to blame?
Micah L Hemani, Charles L Bennett
Urology
|
September 24, 2022
EDITORIAL COMMENT
Kevin B Knopf, Charles L Bennett
Seminars in Oncology
|
February 19, 2005
Pharmacoeconomics of liposomal anthracycline therapy
Charles L Bennett, Elizabeth A Calhoun
The Oncologist
|
May 2, 2007
Evaluating the total costs of chemotherapy-induced febrile neutropenia: results from a pilot study with community oncology cancer patients
Charles L Bennett, Elizabeth A Calhoun
Annals of Internal Medicine
|
July 18, 2002
Hepatotoxicity after prophylaxis with a nevirapine-containing antiretroviral regimen
Stuart Johnson, Juliana Chan, Charles L Bennett
Journal of Evaluation in Clinical Practice
|
April 24, 2019
Failure to place evidence at the centre of quality improvement remains a major barrier for advances in quality improvement
Benjamin Djulbegovic, Charles L Bennett, Gordon Guyatt
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 8, 2005
Acting on imperfect evidence: How much regret are we ready to accept?
Benjamin Djulbegovic, Andrew Frohlich, Charles L Bennett
Cancer Treatment and Research
|
November 30, 2022
Policing of Drug Safety Information Dissemination Under the False Claims Act
Brian Chen, Tony Yang, Charles L Bennett
Journal of Evaluation in Clinical Practice
|
November 22, 2018
A unifying framework for improving health care
Benjamin Djulbegovic, Charles L Bennett, Gordon Guyatt
Annals of Internal Medicine
|
October 2, 2002
Pneumonitis associated with nonsteroidal antiandrogens: presumptive evidence of a class effect
Charles L Bennett, Dennis W Raisch, Oliver Sartor
Page
of 34
Search research articles
Search
Showing results (41-50 of 331) with videos related to
Sort By:
Page
of 34
Cancer
|
June 22, 2010
The excessive cost of early stage bladder cancer care: are providers really to blame?
Micah L Hemani, Charles L Bennett
Urology
|
September 24, 2022
EDITORIAL COMMENT
Kevin B Knopf, Charles L Bennett
Seminars in Oncology
|
February 19, 2005
Pharmacoeconomics of liposomal anthracycline therapy
Charles L Bennett, Elizabeth A Calhoun
The Oncologist
|
May 2, 2007
Evaluating the total costs of chemotherapy-induced febrile neutropenia: results from a pilot study with community oncology cancer patients
Charles L Bennett, Elizabeth A Calhoun
Annals of Internal Medicine
|
July 18, 2002
Hepatotoxicity after prophylaxis with a nevirapine-containing antiretroviral regimen
Stuart Johnson, Juliana Chan, Charles L Bennett
Journal of Evaluation in Clinical Practice
|
April 24, 2019
Failure to place evidence at the centre of quality improvement remains a major barrier for advances in quality improvement
Benjamin Djulbegovic, Charles L Bennett, Gordon Guyatt
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 8, 2005
Acting on imperfect evidence: How much regret are we ready to accept?
Benjamin Djulbegovic, Andrew Frohlich, Charles L Bennett
Cancer Treatment and Research
|
November 30, 2022
Policing of Drug Safety Information Dissemination Under the False Claims Act
Brian Chen, Tony Yang, Charles L Bennett
Journal of Evaluation in Clinical Practice
|
November 22, 2018
A unifying framework for improving health care
Benjamin Djulbegovic, Charles L Bennett, Gordon Guyatt
Annals of Internal Medicine
|
October 2, 2002
Pneumonitis associated with nonsteroidal antiandrogens: presumptive evidence of a class effect
Charles L Bennett, Dennis W Raisch, Oliver Sartor
Page
of 34